ALVIO.PA PAR
Valerio Therapeutics S.A.
1W: -9.1%
1M: -26.2%
3M: +10.7%
YTD: +225.2%
1Y: +731.7%
3Y: +98.0%
€0.51 ($0.57)
-0.02 (-3.78%)
Weekly Expected Move ±6.9%
€0
€0
€1
€1
€1
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Cash Flow Trends
Operating Cash Flow
-$12M
+33.0% ▲
Capital Expenditures
$319K
-74.3% ▼
5Y CAGR: +65.1%
Free Cash Flow
-$13M
+32.0% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+100.0% ▲
Net Change in Cash
-$6M
+27.1% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $1M | -$6M | -$20M | -$20M | -$24M |
| Depreciation & Amort. | -$8M | $511K | -$167K | $507K | $11M |
| Stock-Based Comp. | $79K | $224K | $724K | $514K | $390K |
| Change in Working Capital | $886K | -$4M | $7M | -$665K | -$4M |
| Other Non-Cash Items | $669K | $666K | $2M | $1M | $4M |
| Operating Cash Flow | -$5M | -$9M | -$9M | -$19M | -$12M |
| — Investing Activities — | |||||
| Capital Expenditures | -$119K | -$139K | -$488K | -$183K | -$319K |
| Acquisitions (Net) | $14K | $0 | $0 | $0 | -$1M |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $4K | $73K | $80K | $7K | $9K |
| Other Investing | $6M | $0 | -$1K | -$1K | $1K |
| Investing Cash Flow | $6M | -$66K | -$409K | -$177K | -$1M |
| — Financing Activities — | |||||
| Net Debt Issuance | -$3M | $3M | -$2M | -$1M | -$1M |
| Stock Repurchased | $0 | $0 | $0 | -$125K | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$1K | $4K | $2K | -$7K | $6M |
| Financing Cash Flow | $7M | $12M | $6M | $11M | $4M |
| Net Change in Cash | $9M | $3M | -$3M | -$8M | -$6M |
| Cash End of Period | $15M | $18M | $15M | $7M | $1M |
| Free Cash Flow | -$5M | -$9M | -$10M | -$19M | -$13M |